Literature DB >> 24457249

A new KIT gene mutation in thymic cancer and a promising response to imatinib.

Sung Hee Lim1, Ji-Yun Lee, Jong-Mu Sun, Kyoung-Mee Kim, Jin Seok Ahn, Myung-Ju Ahn, Keunchil Park.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2013        PMID： 24457249     DOI： 10.1097/JTO.0b013e31829d51bd

Source DB:  PubMed          Journal:  J Thorac Oncol        ISSN： 1556-0864            Impact factor:   15.609


× No keyword cloud information.
  2 in total

1.  c-kit mutation-positive advanced thymic carcinoma successfully treated as a mediastinal gastrointestinal stromal tumor: A case report.

Authors:  Fumihiko Hirai; Makoto Edagawa; Shinichiro Shimamatsu; Ryo Toyozawa; Gouji Toyokawa; Kaname Nosaki; Masafumi Yamaguchi; Takashi Seto; Mitsuhiro Twakenoyama; Yukito Ichinose
Journal:  Mol Clin Oncol       Date:  2016-01-28

2.  Targeted Next-Generation Sequencing of Thymic Epithelial Tumours Revealed Pathogenic Variants in KIT, ERBB2, KRAS, and TP53 in 30% of Thymic Carcinomas.

Authors:  Adam Szpechcinski; Malgorzata Szolkowska; Sebastian Winiarski; Urszula Lechowicz; Piotr Wisniewski; Magdalena Knetki-Wroblewska
Journal:  Cancers (Basel)       Date:  2022-07-12       Impact factor: 6.575
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.